IL-11 Antibody (22626) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB218C
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Neutralization, Western Blot
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Monoclonal Mouse IgG2A Clone # 22626
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human IL-11
Pro22-Leu199
Accession # P20809
Pro22-Leu199
Accession # P20809
Specificity
Detects human IL-11 in direct ELISAs and Western blots. In direct ELISAs and Western blots, 100% cross-reactivity with recombinant mouse IL-11 is observed and no cross-reactivity with recombinant human (rh) IL-6, rhCNTF, rhLIF, rhOSM, rhCLC, or rhCT-1 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for IL-11 Antibody (22626) [PerCP]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IL-11
Long Name
Interleukin 11
Alternate Names
AGIF, IL11, Oprelvekin
Gene Symbol
IL11
Additional IL-11 Products
Product Documents for IL-11 Antibody (22626) [PerCP]
Product Specific Notices for IL-11 Antibody (22626) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...